These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2856479)

  • 1. Changes of plasma angiotensin-converting enzyme activity during hemodialysis.
    Koo WS; Lee YJ; Kim HS; Kim SY; Choi EJ; Chang YS; Yoon YS; Bang BK
    Korean J Intern Med; 1987 Jan; 2(1):62-5. PubMed ID: 2856479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium?
    Nielsen AH; Knudsen F; Kristensen SD
    Nephron; 1985; 40(1):100-3. PubMed ID: 2987714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysis.
    Patel R; Ansari A
    Clin Chim Acta; 1979 Mar; 92(3):491-5. PubMed ID: 219970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unspecific increase of blood levels of angiotensin converting enzyme in chronic hemodialysis].
    Leanza HJ; Vivas N; Garcia G; Rivarola G; Najun Zarazaga CJ
    Medicina (B Aires); 1994; 54(2):183. PubMed ID: 7997142
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
    Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
    Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
    Jankova T; Tchankova P; Nenov D
    Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
    Matucci-Cerinic M; Pignone A; Lotti T; Spillantini G; Curradi C; Leoncini G; Iannone F; Falcini F; Cagnoni M
    J Rheumatol; 1990 Mar; 17(3):328-30. PubMed ID: 2159071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide-induced changes of serum angiotensin converting enzyme activity and pulmonary microvessels ultrastructure.
    Musiatowicz B; Terlikowski S; Sulik M; Famulski W; Giedrojć J; Jakubowski A; Sobaniec-Lotowska M; Pasztaleniec L; Baltaziak M; Jabłońska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 2():88-94. PubMed ID: 9646687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum angiotensin-converting enzyme in chronic renal disease.
    Silverstein E; Brunswick J; Rao TK; Friedland J
    Nephron; 1984; 37(3):206-10. PubMed ID: 6330591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive angiotensin I converting enzyme in plasma from normal subjects. Comparison with enzyme activity.
    Yasui T; Alhenc-Gelas F; Daufresne S
    Eur Heart J; 1983 Nov; 4 Suppl G():27-9. PubMed ID: 6319142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting enzyme inhibitors in hemodialysis.
    Bazilinski N
    Int J Artif Organs; 1983 Mar; 6(2):62-4. PubMed ID: 6302010
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum angiotensin-converting enzyme during haemodialysis: effect of membrane biocompatibility.
    Maher ER; Bird R; Kyle P; Curtis JR
    Nephron; 1987; 45(4):328. PubMed ID: 3035394
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
    Wysocki J; Batlle D
    Nephrol Dial Transplant; 2013 Sep; 28(9):2200-2. PubMed ID: 23787547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibility.
    Docci D; Turci F; Baldrati L; Delvecchio C
    Nephron; 1988; 48(4):335. PubMed ID: 2834657
    [No Abstract]   [Full Text] [Related]  

  • 17. Association Between Angiotensin-Converting Enzyme 2 and Coronary Artery Calcification in Patients on Maintenance Hemodialysis Therapy.
    Zhang Q; Sun L; Jin L
    Ther Apher Dial; 2015 Oct; 19(5):466-70. PubMed ID: 26112236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial observations of angiotensin-converting enzyme and pulmonary function in sarcoidosis.
    Weaver LJ; Solliday NH; Celic L; Cugell D
    Arch Intern Med; 1981 Jun; 141(7):931-4. PubMed ID: 6263205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum angiotensin-converting enzyme in end-stage renal disease.
    Rumpf KW; Brat A; Armstrong V; Scheler F
    Nephron; 1985; 40(2):248-9. PubMed ID: 2987717
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between activated renin angiotensin system and bone formation in hemodialysis patients: is the bone mass genetically determined by ACE gene polymorphism?
    Altun B; Kiykim AA; Seyrantepe V; Usalan C; Arici M; Cağlar M; Erdem Y; Yasavul U; Turgan C; Cağlar S
    Ren Fail; 2004 Jul; 26(4):425-31. PubMed ID: 15462112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.